Philip Morris sells cigarettes and smoke-free alternatives like IQOS heated sticks, selling globally everywhere except the US — think of it as the Marlboro maker pivoting to high-tech nicotine devices.
Money comes from recurring, high-margin tobacco sales: gross margin ~67.5% and net margin ~25.6%, with annual revenue of USD 40.65B in 2025, driven by both legacy cigarettes and growing heated-tobacco products.
Strong brand, patented heat-not-burn tech, and distribution lock-in across 71 markets create real barriers, but vaping and oral nicotine rivals like Juul, BAT, and Altria are pressuring shelf space and regulation.
Key events, in time order
Three institutions disclosed new or increased positions, indicating rising institutional interest
Multiple sources confirm PM's increased investment in Zyn capacity, signaling confidence in nicotine pouch market
Revenue beat on strong smoke-free demand, Zyn after regulatory approval
Revenue and adj. EPS beat, but FY profit forecast cut weighs on stock
H1 2026有机净收入增长+5.3%，调整后稀释每股收益增长+9.4%（不含汇率影响），达到$4.16
None yet
None yet
No comments yet.
Facts and opinions separated · All items sourced · Not investment advice
